EMMA CONROY: Open Payments
NPI 1538846472 · HAMBURG, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,044 in 53 payments from 18 companies in 2025. Trend: 2023 $479 · 2024 $978 · 2025 $1,044
Food & beverage: $1,044
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $156 |
| Sequel Med Tech, LLC | 4 | $126 |
| Novo Nordisk Inc | 5 | $101 |
| ABBVIE INC. | 5 | $97 |
| BETA BIONICS, INC. | 7 | $90 |
| Tandem Diabetes Care, Inc. | 2 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $51 |
| Insulet Corporation | 2 | $50 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $44 |
Products named: TWIIST, TEPEZZA, iLet Bionic Pancreas, t:slim X2 Insulin Pump with Control-IQ, UBRELVY, JARDIANCE, Kerendia, Omnipod.
Industry payments across NY — which companies pay providers there.
